Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1998 1
2001 2
2002 3
2003 4
2006 2
2007 2
2010 2
2012 1
2013 2
2014 4
2015 3
2016 2
2017 2
2018 3
2019 3
2020 5
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Essential medicines for universal health coverage.
Wirtz VJ, Hogerzeil HV, Gray AL, Bigdeli M, de Joncheere CP, Ewen MA, Gyansa-Lutterodt M, Jing S, Luiza VL, Mbindyo RM, Möller H, Moucheraud C, Pécoul B, Rägo L, Rashidian A, Ross-Degnan D, Stephens PN, Teerawattananon Y, 't Hoen EF, Wagner AK, Yadav P, Reich MR. Wirtz VJ, et al. Among authors: t hoen ef. Lancet. 2017 Jan 28;389(10067):403-476. doi: 10.1016/S0140-6736(16)31599-9. Epub 2016 Nov 8. Lancet. 2017. PMID: 27832874 Free PMC article. Review. No abstract available.
Global hepatitis C elimination: an investment framework.
Pedrana A, Howell J, Scott N, Schroeder S, Kuschel C, Lazarus JV, Atun R, Baptista-Leite R, 't Hoen E, Hutchinson SJ, Aufegger L, Peck R, Sohn AH, Swan T, Thursz M, Lesi O, Sharma M, Thwaites J, Wilson DP, Hellard M. Pedrana A, et al. Among authors: t hoen e. Lancet Gastroenterol Hepatol. 2020 Oct;5(10):927-939. doi: 10.1016/S2468-1253(20)30010-8. Epub 2020 Jul 27. Lancet Gastroenterol Hepatol. 2020. PMID: 32730786 Review.
[Orphan drugs and drug pirates].
Bannenberg WJ, 't Hoen EFM. Bannenberg WJ, et al. Among authors: t hoen efm. Ned Tijdschr Geneeskd. 2020 Jun 18;164:D4776. Ned Tijdschr Geneeskd. 2020. PMID: 32749801 Dutch.
Compulsory Licenses For Medicines.
't Hoen E, Bermudez J. 't Hoen E, et al. Health Aff (Millwood). 2015 Jun;34(6):1068. doi: 10.1377/hlthaff.2015.0452. Health Aff (Millwood). 2015. PMID: 26056219 No abstract available.
A global investment framework for the elimination of hepatitis B.
Howell J, Pedrana A, Schroeder SE, Scott N, Aufegger L, Atun R, Baptista-Leite R, Hirnschall G, 't Hoen E, Hutchinson SJ, Lazarus JV, Olufunmilayo L, Peck R, Sharma M, Sohn AH, Thompson A, Thursz M, Wilson D, Hellard M. Howell J, et al. Among authors: t hoen e. J Hepatol. 2021 Mar;74(3):535-549. doi: 10.1016/j.jhep.2020.09.013. Epub 2020 Sep 22. J Hepatol. 2021. PMID: 32971137 Free PMC article.
Improving affordability of new Essential Cancer Medicines.
't Hoen E, Meyer S, Durisch P, Bannenberg W, Perehudoff K, Reed T, Barber MJ. 't Hoen E, et al. Lancet Oncol. 2019 Aug;20(8):1052-1054. doi: 10.1016/S1470-2045(19)30459-0. Epub 2019 Jul 11. Lancet Oncol. 2019. PMID: 31303433 No abstract available.
Essential medicines are still essential.
Gray AL, Wirtz VJ, 't Hoen EF, Reich MR, Hogerzeil HV. Gray AL, et al. Among authors: t hoen ef. Lancet. 2015 Oct 24;386(10004):1601-3. doi: 10.1016/S0140-6736(15)00514-0. Lancet. 2015. PMID: 26595616 No abstract available.
Compensation for diethylstilbestrol injury.
't Hoen EF, Dukes MN. 't Hoen EF, et al. Lancet. 2007 Jan 20;369(9557):173-4. doi: 10.1016/S0140-6736(07)60087-7. Lancet. 2007. PMID: 17240270 No abstract available.
43 results